Verastem: Fourth Quarter Financial Results Overview
Verastem Inc. Reports Fourth Quarter Financial Results
Verastem Inc., a pharmaceutical company based in Needham, Massachusetts, announced a net loss of $32.9 million for the fourth quarter.
This translates to a loss of 50 cents per share during the quarter.
The company generated $17.5 million in revenue over the same period.
For the full year, Verastem reported a total loss of $209.5 million, or $3.02 per share, with annual revenue reaching $30.9 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The SoFi Sell Off Is a Massive Opportunity
Kinder Morgan (KMI) Gets Target Boost from Morgan Stanley; RBC Also Lifts Forecast
Mizuho Downgrades AES After $10.7 Billion Takeover Agreement
GAP Gets Higher Target From Telsey Advisory on Brand Revitalization Efforts
Trending news
MoreCrypto prices
More
